Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-030964

Chief Operating Officer acquired 968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Radovich Peter Chief Operating Officer 2023-05-10 Grant or award +968 $16.92 $16,382 39,100 D
Loading xslF345X04/doc4.xml…